Trial intelligence / Profile preview

OVER trial of 1 L PEG + ascorbate versus 4 L PEG for bowel preparation before colonoscopy

2018-004543-24Phase 4Active

Sponsor
Ospedale Fatebenefratelli
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of polyethylene glycol + electrolytes + ascorbic acid and Selg Esse (2 arms), sponsored by Ospedale Fatebenefratelli. Primary endpoint: Adequate bowel cleansing non-inferiority. Started Nov 2020; status: active.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acidSelg Esse

Beyond the preview

Go deeper on 2018-004543-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004543-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call